A fourth dimension in decision making in hepatology

Yaron Ilan1

  • 1Gastroenterology and Liver Units, Deparent of Medicine, Hadassah Hebrew University Medical Center; Jerusalem, Israel.

Insights

The (13)C methacetin breath test (MBT) offers a rapid, non-invasive method for assessing liver function. This point-of-care tool aids clinical decisions in managing acute and chronic liver disease patients.

Area of Science:

  • Hepatology
  • Medical Diagnostics
  • Biochemistry

Background:

  • Current liver function tests (biopsy, blood tests) often lack sensitivity for timely patient follow-up.
  • Accurate liver function assessment is crucial for prognosis and treatment decisions in liver disease.
  • Existing methods provide only indirect evidence of hepatic impairment.

Purpose of the Study:

  • To review the utility of the point-of-care (13)C methacetin breath test (MBT) for assessing hepatic functional reserve.
  • To highlight the MBT's role in clinical decision-making for liver disease management.
  • To present treatment algorithms informed by MBT results.

Main Methods:

  • Utilizes the liver-specific metabolism of (13)C-labeled methacetin.
  • Employs molecular correlation spectroscopy to measure exhaled (13)C.
  • Focuses on a rapid, non-invasive, point-of-care breath test approach.

Main Results:

  • The (13)C MBT accurately assesses liver metabolic function.
  • Demonstrates the test's ability to evaluate hepatic functional reserve in acute and chronic liver disease.
  • Provides a sensitive measure for patient follow-up and treatment guidance.

Conclusions:

  • The (13)C MBT is a valuable tool for bedside decision-making in clinical hepatology.
  • Enables precise assessment of liver function, aiding in prognosis and treatment planning.
  • Facilitates timely interventions for patients with liver disorders.

Related Concept Videos

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...
Dimensions of Health and Illness01:21

Dimensions of Health and Illness

The factors influencing the health-illness continuum can be internal or external and may or may not be under conscious control. They are related to the following eight human dimensions, and each dimension is interrelated to one other.
Effect of Hepatic Disease on Pharmacokinetics: Active Drug, Metabolite and Fraction of Metabolized Drug01:14

Effect of Hepatic Disease on Pharmacokinetics: Active Drug, Metabolite and Fraction of Metabolized Drug

In pharmacotherapy, monitoring drug concentrations is paramount, especially for drugs whose therapeutic effects hinge on both the active compound and its metabolite. Hepatic impairment profoundly influences drug potency by altering liver function. If the drug is more potent than its metabolite, impaired liver function amplifies drug activity due to elevated drug concentration levels. Conversely, if the metabolite holds greater potency, diminished liver function diminishes drug activity by...
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment01:08

Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment

Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
Decision Making01:20

Decision Making

Decision-making is a fundamental cognitive process that involves evaluating alternatives and selecting among them. This process can range from simple choices, such as deciding what to wear, to complex decisions, like choosing a major in college or a career path. The complexity of the decision often dictates the approach we use, which can be broadly categorized into two types: automatic and controlled decision-making.
Automatic decision-making is fast, intuitive, and relies on gut feelings...